HBS Ag (Hepatitis B Surface Antigen) CLIA

Overview:
The HBs Ag (Hepatitis B Surface Antigen) CLIA test is a diagnostic test used to detect the presence of the Hepatitis B surface antigen in the blood. The presence of this antigen indicates an active Hepatitis B infection. CLIA (Chemiluminescent Immunoassay) is the method used for detection, which offers high sensitivity and specificity.

What it detects:
This test detects the Hepatitis B surface antigen (HBsAg), a protein on the surface of the Hepatitis B virus. If present, it suggests that the person is either infected with the Hepatitis B virus (HBV) or is a carrier of the infection, capable of transmitting the virus to others.

Who should get it:
Individuals who have symptoms of Hepatitis B (such as jaundice, fatigue, and abdominal pain), those who have had potential exposure to the virus (e.g., through unprotected sex, needle sharing, or blood transfusions), or those who are at high risk (e.g., healthcare workers, people with a history of intravenous drug use) should consider this test.

Sample required:
A blood sample is required for this test.

Fasting requirements:
Fasting is not required for this test.

Processing time:
Results available within 24-48 hours.